TrialCNS drugs2019

A Multi-Center, Open-Label, Pharmacokinetic Drug Interaction Study of Erenumab and a Combined Oral Contraceptive in Healthy Females.

Yang Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.